Baker Bros. Advisors’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
Other funds holding VTYX
Baker Bros. Advisors's VTYX Position: Q1 2026 in Review
Baker Bros. Advisors sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 2,349,280 shares — an estimated $21.2M sold.
Baker Bros. Advisors first reported a position in VTYX in Q3 2025 and held it in 2 quarters. The position peaked at $21.2M in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.
- Baker Bros. Advisors reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
- Baker Bros. Advisors sold 2,349,280 Ventyx Biosciences shares in Q1 2026, an estimated $21.2M.
- Baker Bros. Advisors first reported a position in Ventyx Biosciences in Q3 2025 and held it in 2 quarters.
- Baker Bros. Advisors's Ventyx Biosciences position peaked at $21.2M in Q4 2025.
- 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.
Based on Baker Bros. Advisors's 13F filing for Q1 2026, filed 15 May 2026.